CClinicalTrials.gg
WithdrawnNCT04815681Updated Jun 11, 2025

Evaluating an Online Wellness Intervention for Greek Adolescents

An interventional study of Common Elements Toolbox and Active Control in Depressive Symptoms, Anxiety and Happiness, sponsored by University of Pennsylvania. Withdrawn at 2 sites in 2 countries. Open to participants aged 13 Years to 20 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-11.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Prevention

Why this study was withdrawn
unable to enroll participants
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
13 Years to 20 Years
Sex
All
01

Study summary

The investigators are evaluating the effects of an online single-session mental health intervention (the Common Elements Toolbox; COMET). To evaluate COMET, the investigators are conducting a randomized controlled trial with Greek adolescents attending high school in the Attica region in Greece. Students will be randomized to the COMET condition or to an active control condition.

Primary outcome measures (depressive symptoms, anxiety symptoms, subjective well-being) will be measured at two weeks post-intervention and four weeks post-intervention.

The investigators will evaluate COMET as a universal intervention (using the full sample) and as a targeted intervention (analyzing those who reported elevated depressive symptoms or anxiety symptoms at baseline).

02

Conditions studied

  • Depressive Symptoms
  • Anxiety
  • Happiness

Browse trials for

03

In context

Depression

8,055 studies on the registry are indexed under Depression; 1,643 are open to participants now.

Browse Depression studies →

Lead sponsor

University of Pennsylvania is the lead sponsor of 1,635 studies on the registry; 239 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 104 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Between 13 and 20 years old and a student at a participating Greek high school. Access to the internet.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Common Elements Toolbox (COMET)

    Behavioral: Common Elements Toolbox

  • Active comparator
    Active Control Condition

    Behavioral: Active Control

Interventions

  • BehavioralCommon Elements Toolbox

    COMET is an online unguided self-help intervention that lasts approximately 40-50 minutes.

    Also known as: COMET

  • BehavioralActive Control

    The active control condition includes an online self-awareness program that lasts approximately 40-50 minutes. Participants in the control condition will receive access to the intervention after data collection for the study has been completed.

06

What researchers measure

Primary outcomes

  1. Change in Patient Health Questionnaire-8 (PHQ-8)

    Depression questionnaire. Scores range from 0 to 24. Lower scores indicate less depression.

    Time frame: Up to 4 weeks post-intervention

  2. Change in Generalized Anxiety Disorder Screener-7 (GAD-7)

    Anxiety questionnaire. Total scores range from 0-21. Lower scores indicate less anxiety.

    Time frame: Up to 4 weeks post-intervention

  3. Change in the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS)

    Subjective Well-being questionnaire. Total scores range from 7 to 35. Higher values indicate higher well-being scores.

    Time frame: Up to 4 weeks post-intervention

Secondary outcomes

  1. Ratings on the Acceptability of Intervention Measure (AIM)

    Questionnaire measuring the acceptability of an intervention. Acceptability refers to the perception that a given treatment is agreeable or satisfactory. The total score ranges from 4 to 20. Higher scores indicate higher acceptability ratings.

    Time frame: Immediately after the intervention

  2. Ratings on the Intervention Appropriateness Measure (IAM)

    Questionnaire measuring the appropriateness of an intervention. Appropriateness refers to the perceived fit or relevance of an intervention. The total score ranges from 4 to 20. Higher scores indicate higher appropriateness.

    Time frame: Immediately after the intervention

  3. Secondary Control

    The investigators will ask participants three items to assess secondary control (Weisz et al., 2010). The items are scored on a 4-point Likert scale, ranging from 0 ("Very false") to 3 ("Very true"). The three items are: When something bad happens, I can find a way to think about it that makes me feel better. After a really hard day, I can make myself feel better by remembering some good things that happened. When bad things happen to me that I can't control, there are lots of things I can do to feel better. Higher scores indicate greater secondary control.

    Time frame: Up to 4 weeks post-intervention

  4. Perceived Utility

    Participants will be asked to rate three items relating to the perceived utility of each module. Specifically, the investigators asked participants: How helpful the module was; How engaging the module was; How much they will continue applying content from the module. If items are at least moderately correlated (r \> .5) the investigators will combine them in a single measure of perceived utility. Higher scores indicate greater perceived utility.

    Time frame: Immediately after intervention

  5. Positive and Negative Affect Schedule (PANAS)

    Questionnaire measuring positive affect and negative affect. Scores on the positive affect subscale range from 10-50, with higher scores representing higher levels of positive affect. Scores on the negative affect subscale range from 10-50, with lower scores representing lower levels of negative affect.

    Time frame: Up to 4 weeks post-intervention

07

Study locations

2 sites
  • University of Pennsylvania
    Philadelphia, Pennsylvania 19104, United States
  • Eginition Hospital National and Kapodistrian University of Athens School of Medicine
    Athens, 15121, Greece
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04815681
Lead sponsor
University of Pennsylvania
Collaborators
National and Kapodistrian University of Athens, Greece, University Mental Health, Neurosciences and Precision Medicine Research Institute "Costas Stefanis," Greece
Responsible party
Sponsor
First posted
Mar 25, 2021
Start date
Mar 2021 (estimated)
Primary completion
Jun 2022 (estimated)
Completion
Dec 2022 (estimated)
Last update
Jun 11, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion